Found: 13
ОБЗОР2026 · pp. 107–116
Morozov A.M., Sorokovikova T.V., Kuzmenko A.D., Shablinskaya K.S.
Introduction. Cerebrovascular diseases are a heterogeneous group of conditions shaped by the interaction of polygenic susceptibility, rare monogenic variants, vascular remodeling, neuroinflammation, dysregulated hemostasis, and epigenetic reprogramming. Recent…
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2026 · pp. 3–8
Khaspekov L.G., Mudarisova R.S., Kolotyeva N.A., Salmina A.B., Li W., Illarioshkin S.N.
Introduction. Parkinson’s disease (PD) is a chronic, progressive neurodegenerative disorder, the primary pathological feature of which is the death of dopaminergic neurons in the substantia nigra pars compacta and the accumulation of aggregated α-synuclein. Th…
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2025 · pp. 58–69
Kondrahin A.P., Silina E.G., Chernyaeva M.S., Maksimov M.L., Belokopytov A.S., Babichev A.N., Smirnova Yu.E., Martynova S.A., Schnаider K.O.
Introduction. Thanks to the achievements of modern medicine, it was possible to significantly increase the life expectancy of the population. Molecular mechanisms of aging include telomere shortening, DNA damage accumulation, mitochondrial dysfunction, leading…
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2025 · pp. 54–59
Lobanova O.A., Gaikovaya L.B., Sirotkina O.V., Kukharchik G.A., Ermakov A.I., Zagorodnikova K.A.
Introduction. Chronic heart failure is a multifactorial disease, an important role in the pathogenesis of which is played by disorders of the functions of mitochondria and energy metabolism in cardiomyocytes, as well as a significant contribution is made by ge…
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2024 · pp. 43–51
Leontieva D.O., Zubareva A.S., Korovin A.E., Grishin A.P., Tovpeko D.V., Fedotkina T.V., Churilov L.P.
Introduction. Mitochondrial dysfunction is an important pathogenic mechanism of neurodegeneration, characterized by a progressive structural and functional loss of neurons, leading to heterogeneous clinical and pathological manifestations with subsequent impai…
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2023 · pp. 58–64
Pozdnyakov D.I.
Introduction. Ischemic stroke is one of the most common causes of mortality and primary disability. The treatment of ischemic stroke, especially its complications, includes neuroprotective agents among which correctors of mitochondrial dysfunction stand out. A…
ОБЗОР2022 · pp. 3–9
Paltzev M.A., Zubareva T.S., Zubareva A.S., Leontyeva D.O., Mironova E.S., Kvetnoy I.M.
Mitochondria are the active cell organelles whose structures (the membrane in particular) express a large number of signaling molecules, proteins mainly, that play an important regulatory role in cell active functioning. The biological activity of mitochondria…
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2022 · pp. 54–59
Pozdnyakov D.I.
Introduction. Neuroprotection in traumatic brain injury is a promising area of therapy for cerebral disorders. Neuroprotective effect can be implemented by a action on variety molecular targets, a change in the activity of which leads to the elimination of pat…
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2022
Kvetnoy I.M., Mironova E.S., Krylova Y.S., Mylnikova A.A., Zubareva T.S., Leont’eva D.O., Polyakova V.O., Petrosyan M.A.
Introduction. Oxidative stress and mitochondrial dysfunction are observed in virtually any disease associated with premature aging. Signaling molecules produced by mitochondria can act as specific targets for the action of pharmacological agents in order to re…
ПЕРЕДОВАЯ СТАТЬЯ2018
Paltsev M.A., Zuev V.A., Diatlova A.S., Linkova N.S., Kvetnaia T.V.
Parkinson’s disease (PD) is a progressive, age-related, neuronal disorder that affects as much as 1% of the persons over 65 years. According to forecasts of the World Health Organization over the world about 9 million people will suffer from PD by 2030. So PD …
ПЕРЕДОВАЯ СТАТЬЯ2016
Paltsev M.A., Polyakova V.O., Linkova N.S., Paltseva E.M., Kvetnaia T.V., Zuev V.A., Kvetnoy I.M., Popuchiev V.V.
Alzheimer's disease being the socially significant neurodegenerative disease of the elderly, ranks 6th on the causes of death among somatic pathologies. The molecular mechanisms of Alzheimer's disease still remain unexplored until the end, and the efficacy of …
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2016
Syrkasheva A.G., Krasny A.M., Mayorova T.D., Makarova N.P., Dolgushina N.V.
Introduction. In IVF-cycles ≈70% of human oocytes have different morphological abnormalities (dysmorphisms). Embryos from dysmorhic oocytes may have delay in development due to mitochondrial dysfunction and disorders of energy accumulation in the cell. The aim…
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ
Kvetnoy I.M., Mironova E.S., Krylova Y.S., Mylnikova A.A., Zubareva T.S., Leont’eva D.O., Polyakova V.O., Petrosyan M.A.
Introduction. Oxidative stress and mitochondrial dysfunction are observed in virtually any disease associated with premature aging. Signaling molecules produced by mitochondria can act as specific targets for the action of pharmacological agents in order to re…